CIK 0000943819
- Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980152841
- Phone
- +1 858-746-2400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- 4 Planned sale Chief Financial Officer sold 1,000 shares at $230.36 ($230,360)
- 4 Planned sale Chief Commercial Officer, SaaS sold 9,745 shares at $239.31 ($2,332,096)
- 4 Planned sale Chief Executive Officer sold 8,009 shares at $229.20 ($1,835,692)
- 4 Planned sale Director sold 2,000 shares at $227.71 ($455,420)
- 4 Planned sale Chief Commercial Officer, SaaS sold 9,113 shares at an average $235.40 ($2,145,186)
- 4 Planned sale Global General Counsel sold 64 shares at $234.10 ($14,982)
- 4 Planned sale Chief Financial Officer sold 1,000 shares at $238.98 ($238,980)
- 4 Planned sale Chief Executive Officer sold 8,009 shares at $236.77 ($1,896,307)
- 4 Planned sale Director sold 2,000 shares at $242.11 ($484,220)
- 4 Planned sale Global General Counsel sold 64 shares at $242.42 ($15,515)
- 4 Planned sale Chief Financial Officer sold 1,000 shares at $234.04 ($234,040)
- 4 Planned sale Director sold 2,000 shares at $230.99 ($461,980)
- 4 Planned sale Global General Counsel sold 75 shares at $230.99 ($17,324)
- 4 Planned sale Chief Financial Officer sold 1,000 shares at $244.23 ($244,230)
- 4 Planned sale Director sold 2,000 shares at $245.65 ($491,300)
- 4 Planned sale Global General Counsel sold 74 shares at $248.91 ($18,419)
- 4 Open-market sale Chief Executive Officer sold 2,000 shares at $249.67 ($499,330)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Product Officer sold 6,160 shares at $243.09 ($1,497,416)
- 4 Grant or award Director acquired 1,083 shares (grant or award)
Page 6 of 92 · 1,833 filings